Evidence map›Paper›PMID 29790844›Full record

SynthesisPaediatrics and international child health2018

Antibiotic use for community-acquired pneumonia in neonates and children: WHO evidence review.

Shrey Mathur, Aline Fuchs, Julia Bielicki, Johannes Van Den Anker, Mike Sharland

Open access · hybridAbstract readSystematic Review
In one paragraph

Synthesis in Paediatrics and international child health, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed, 2 pooled it
8.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 2 syntheses or guidelines pooled it, 129 citations in OpenAlex.

  1. Antimicrobial resistance in paediatricThe Lancet. Microbe · 2021
    Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Observational
  17. Article
  18. Article
  19. Article
  20. Auxiliary Pneumonia Classification Algorithm Based on Pruning Compression.Computational and mathematical methods in medicine · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 3 countries.

Shrey Mathura Paediatric Infectious Disease Research Group, Institute for Infection and Immunity , St George's University of London , London , UK.ORCID 0000-0002-2809-8244
Aline Fuchsb Paediatric Pharmacology and Pharmacometrics , University Children's Hospital Basel , Basel , Switzerland.
Julia Bielickia Paediatric Infectious Disease Research Group, Institute for Infection and Immunity , St George's University of London , London , UK.
Johannes Van Den Ankerb Paediatric Pharmacology and Pharmacometrics , University Children's Hospital Basel , Basel , Switzerland.
Mike Sharlanda Paediatric Infectious Disease Research Group, Institute for Infection and Immunity , St George's University of London , London , UK.
St George's, University of London · GBChildren's National · USUniversity Children’s Hospital Basel · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background Pneumonia is the most common cause of death in children worldwide, accounting for 15% of all deaths of children under 5 years of age. This review summarises the evidence for the empirical antibiotic treatment of community-acquired pneumonia in neonates and children and puts emphasis on publications since the release of the previous WHO Evidence Summary report published in 2014. Methods A systematic search for systematic reviews and meta-analyses of antibiotic therapy for community-acquired pneumonia was conducted between 1 January 2013 and 10 November 2016. Results The optimal dosing recommendation for amoxicillin remains unclear with limited pharmacological and clinical evidence. There is limited evidence from surveillance to indicate whether amoxicillin or broader spectrum antibiotics (e.g. third-generation cephalosporins) are being used most commonly for paediatric CAP in different WHO regions. Data are lacking on clinical efficacy in the context of pneumococcal, staphylococcal and mycoplasma disease and the relative contributions of varying first-line and step-down options to the selection of such resistance. Conclusion Further pragmatic trials are required to optimise management of hospitalised children with severe and very severe pneumonia.

Indexed as

AdolescentAmoxicillinAnti-Bacterial AgentsCephalosporinsChildChild, PreschoolCommunity-Acquired InfectionsGuidelines as TopicHumansInfantInfant, NewbornPneumonia, BacterialWorld Health OrganizationAmoxicillinAnti-Bacterial AgentsCephalosporinsAAD, antibiotic-associated diarrhoeaantimicrobial resistancebacterialBNFc, British National Formulary for ChildrenBTS, British Thoracic SocietyCAP, community-acquired pneumoniacommunity-acquired pneumoniaCPS, Canadian Paediatric SocietyEARS-Net, European Antimicrobial Resistance Surveillance NetworkESPID, European Society for Paediatric Infectious DiseasesGRADE, Grading of Recommendations Assessment, Development and EvaluationIDSA, Infectious Diseases Society of AmericaIMCI, integrated management of childhood illnessPCV, pneumococcal conjugate vaccinePIDS, Pediatric Infectious Diseases SocietyPneumoniaRCPCH, Royal College of Paediatrics and Child HealthWHO, World Health Organization

Identifiers

PMID29790844
PMCPMC6176769
OpenAlexW2809388401

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.